McKesson Oncology & Multispecialty

Every day, individual oncology practices support patients by offering both compassion and advanced cancer care. But while each practice is doing important work on its own, there's so much more that we can accomplish when we work together. In its latest annual report, The US Oncology Network discusses how McKesson's Oncology & Multispecialty ecosystem brings together a robust support structure that ensures every patients receives the best possible treatment. Get the full report below. #CommunityOncology #PatientCenteredCare #CancerCare #FutureReadyHealthcare #StrongerTogetherInCare

Transforming real-world data into actionable insights is an important part of moving cancer care forward. But that data has to be usable—and trustworthy. Ontada and McKesson Compile recently put together a survey of 100 senior-level life sciences professionals to determine how linked oncology real-world data is being used. Respondents brought home the importance of data quality, not just quantity. Learn more about the report and its findings: https://lnkd.in/ex4NfCyE #RWD #LifeSciences #Integrated Data #LinkedOncologyData #FutureReadyHealthcare

McKesson Accelerate is coming up on November 16-18, 2026! Join us for three days of actionable education, peer-to-peer learning, and networking in the areas most important to community oncology today: —Practice management: Implementing strategies that streamline workflows and drive sustainable growth —Novel therapies: Sharing insights into the latest therapies and other protocols, including how they are reshaping treatment —Technology and AI: Learning how to implement AI-driven tools and make use of the latest technology breakthroughs —Enhancing patient care: Bringing together proven methodologies to boost patient satisfaction scores and improve care Check your email for your invitation to register! We hope to see you there. Find out more: https://lnkd.in/gidrZYKS #McKessonAccelerate #CommunityOncology #InnovationInCare #FutureReadyHealthcare #StrongerTogetherInCare

As the complexity of access to care grows, field reimbursement services programs need to be able to scale and adapt. This on-demand webinar co-sponsored by Informa and CoverMyMeds takes a look at how field reimbursement services programs can move beyond foundational support, adapt to shifting access dynamics, and use insights to drive informed strategy. "Scaling Mature Field Reimbursement Programs with Confidence" features Brandy Fidler, Editor, Business Strategy, BioXconomy; Patrick Sadongo, Senior Manager, Field Reimbursement Services, CoverMyMeds; and Kim Howard, Senior Manager, Field Reimbursement Services, CoverMyMeds. Learn more below. #FieldReimbursement #HealthcareStrategy #MakingSpecialtyCarePossible #SupportingCommunityCare #ConnectedForCare

FDA approval is vital to making innovative treatments available to patients, but the process can be costly and time-consuming. Meanwhile, patients aren't getting the level of care that they could be. That's where the 505(b)(2) oncology drug pathway comes in. It can make the approval process a little easier, building off of previous research and focusing on what's new or different from previous therapies. In this episode of the Treating Together podcast, Nicholas Brady Informatics at Central Arkansas Radiation Therapy Institute (CARTI); Derek Burns, Pharm.D., MBA, BCPS, BCSCP, Senior Director, MID Solutions at McKesson; and Jessica White, PharmD, Vice President, Specialty Programs & Portfolio Management at McKesson, discuss how the 505(b)(2) oncology drug pathway works and what billing, coding, and workflow steps practices need for safe adoption. Listen to the full episode here: https://lnkd.in/gW8rQcER #FDA505b2 #ClinicalDrugDevelopment #AdvancingHealthOutcomes #CancerTreatment #OncologyCare

Sometimes, the best way to drive innovative solutions is to make a game of it! McKesson's Provider Solutions recently ran its first Innovation Hackathon. Cross-functional teams came together from different parts of the business, including engineering, product, strategy, and customer-facing roles. The goal was for every team to start with a real customer problem in independent specialty care and build a working prototype in a single day. Every idea had to clear three filters: a real customer pain point, McKesson's right to solve it, and a credible path to value. By the end of the day, four working prototypes were created, the strongest of which is already moving toward development. This phenomenal event showed the power of collaboration—and proved that we can go from problem to working software solution in weeks, not years. Congrats to everyone who participated! #ProviderSolutions #AI #FutureReadyHealthcare #AcceleratingDiscovery #StrongerTogetherInCare

Integrating new tools and technologies can significantly improve care—if we use them strategically to allow for more time spent with patients. In this article, Ontada's Rob Helton DPT, Chief Product Officer, looks at the ongoing shift to the Intelligent Medical Record (iMR), a new approach to clinical workflows that brings together AI, clinical trial matching, and more to simplify records and encourage better patient care. Learn more below. #EMR #iMR #AI #PrecisionMedicine #FutureReadyHealthcare

The McKesson Oncology & Multispecialty ecosystem is built around the idea that by combining our skills and resources, we can make sure patients will always have a trusted partner they can turn to. That's why we're proud to announce that Biologics by McKesson recently received a score of 97.6 on the Medallia + The Arnold P. Gold Foundation Humanism Trust Tool. This tool is designed to measure and evaluate trust and human connection in healthcare. Congrats to everyone at Biologics for this impressive recognition! Find out more about the importance of this score below. #PatientCenteredCare #PersonalizedCare #KeepHealthcareHuman #SpecialtyPharmacy #CareDeliveryExcellence

High-quality specialty care can only happen when we are all connected—and when that care is available to everyone who needs it. By bringing together providers, technology, analytics, and research, we can expand access to innovative therapies and transform the way cancer care is delivered. Learn more about how we're making it happen in the latest McKesson Impact Report: https://lnkd.in/euMqKAUB #CommunityOncology #CancerCare #ClinicalTrials #AdvancingHealthOutcomes #StrongerTogetherInCare

As AI becomes increasingly integrated into healthcare, ensuring providers can use it effectively to support better clinical decision-making and more personalized patient care has never been more important. In this article from Healio | HemOnc Today, Debra Patt, MD PhD MBA FASCO, President of the Community Oncology Alliance and Executive Vice President of Policy and Strategy at Texas Oncology, discusses a recent study's findings on the opportunities and challenges AI presents for both training and patient care. Learn more below. #AI #HealthcareInnovation #ASCO26 #InnovationInCare #FutureReadyHealthcare